Kevin Kemp

2.7k total citations
70 papers, 2.1k citations indexed

About

Kevin Kemp is a scholar working on Molecular Biology, Genetics and Cellular and Molecular Neuroscience. According to data from OpenAlex, Kevin Kemp has authored 70 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 20 papers in Genetics and 17 papers in Cellular and Molecular Neuroscience. Recurrent topics in Kevin Kemp's work include Mesenchymal stem cell research (19 papers), Neurogenesis and neuroplasticity mechanisms (13 papers) and Genetic Neurodegenerative Diseases (9 papers). Kevin Kemp is often cited by papers focused on Mesenchymal stem cell research (19 papers), Neurogenesis and neuroplasticity mechanisms (13 papers) and Genetic Neurodegenerative Diseases (9 papers). Kevin Kemp collaborates with scholars based in United Kingdom, United States and Denmark. Kevin Kemp's co-authors include Alastair Wilkins, Neil Scolding, Kelly Hares, Elizabeth Mallam, Claire M Rice, Mark Ginty, Elizabeth Gray, Jill Hows, Craig Donaldson and Juliana Redondo and has published in prestigious journals such as The Lancet, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Kevin Kemp

68 papers receiving 2.0k citations

Peers

Countries citing papers authored by Kevin Kemp

Since Specialization

Citations

This map shows the geographic impact of Kevin Kemp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin Kemp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin Kemp more than expected).

Fields of papers citing papers by Kevin Kemp

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin Kemp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin Kemp. The network helps show where Kevin Kemp may publish in the future.

Co-authorship network of co-authors of Kevin Kemp

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin Kemp. A scholar is included among the top collaborators of Kevin Kemp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin Kemp. Kevin Kemp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	An open-label pilot study of recombinant granulocyte-colony stimulating factor in Friedreich’s ataxia 2022 ·Nature Communications ·Kevin Kemp, (unknown), Kelly Hares, Juliana Redondo, Stephen Bailey, Claire M Rice, Neil Scolding, Chris Metcalfe, Alastair Wilkins	2
2	KIF5A and the contribution of susceptibility genotypes as a predictive biomarker for multiple sclerosis 2021 ·Journal of Neurology ·Kelly Hares, Kevin Kemp, Samantha Loveless, Claire M Rice, Neil Scolding, Emma Tallantyre, Neil P. Robertson, Alastair Wilkins	7
3	Evaluation of the quality of RNA extracted from archival FFPE glioblastoma and epilepsy surgical samples for gene expression assays 2018 ·Journal of Clinical Pathology ·Harry R. Haynes, (unknown), Kelly Hares, Juliana Redondo, Kevin Kemp, Karwan Moutasim, Claire Faulkner, Alastair Wilkins, Kathreena M. Kurian	13
4	Aberrant cerebellar Purkinje cell function repaired in vivo by fusion with infiltrating bone marrow-derived cells 2018 ·Acta Neuropathologica ·Kevin Kemp, (unknown), Johan Verhagen, Neil Scolding, Maria M. Usowicz, Alastair Wilkins	15
5	Reduced neuroprotective potential of the mesenchymal stromal cell secretome with ex vivo expansion, age and progressive multiple sclerosis 2017 ·Cytotherapy ·(unknown), Juliana Redondo, Kevin Kemp, Mark Ginty, Alastair Wilkins, Neil Scolding, Claire M Rice	29
6	Oxidative injury in multiple sclerosis cerebellar grey matter 2016 ·Brain Research ·Kevin Kemp, Juliana Redondo, Kelly Hares, Claire M Rice, Neil Scolding, Alastair Wilkins	22
7	Cell fusion in the brain: two cells forward, one cell back 2014 ·Acta Neuropathologica ·Kevin Kemp, Alastair Wilkins, Neil Scolding	28
8	Increased microglial catalase activity in multiple sclerosis grey matter 2014 ·Brain Research ·Elizabeth Gray, Kevin Kemp, Kelly Hares, Juliana Redondo, Claire M Rice, Neil Scolding, Alastair Wilkins	21
9	The Platform Protein Is Essential for Type IV Pilus Biogenesis 2013 ·Journal of Biological Chemistry ·(unknown), Kevin Kemp, Melissa Kim, P. Lynne Howell, Lori L. Burrows	84
10	Human Mesenchymal Stem Cells Increase Anti-oxidant Defences in Cells Derived from Patients with Friedreich’s Ataxia 2012 ·The Cerebellum ·(unknown), Kevin Kemp, Elizabeth Gray, Claire M Rice, Neil Scolding, Alastair Wilkins	22
11	The PPAR-gamma agonist pioglitazone protects cortical neurons from inflammatory mediators via improvement in peroxisomal function 2012 ·Journal of Neuroinflammation ·Elizabeth Gray, Mark Ginty, Kevin Kemp, Neil Scolding, Alastair Wilkins	79
12	Changes in Expression of the Antioxidant Enzyme SOD3 Occur Upon Differentiation of Human Bone Marrow-Derived Mesenchymal Stem Cells In Vitro 2011 ·Stem Cells and Development ·Helen Nightingale, Kevin Kemp, Elizabeth Gray, Kelly Hares, Elizabeth Mallam, Neil Scolding, Alastair Wilkins	31
13	Peroxisome proliferator-activated receptor-α agonists protect cortical neurons from inflammatory mediators and improve peroxisomal function 2011 ·European Journal of Neuroscience ·Elizabeth Gray, Mark Ginty, Kevin Kemp, Neil Scolding, Alastair Wilkins	31
14	Inflammatory Cytokine Induced Regulation of Superoxide Dismutase 3 Expression by Human Mesenchymal Stem Cells 2010 ·Stem Cell Reviews and Reports ·Kevin Kemp, Elizabeth Gray, Elizabeth Mallam, Neil Scolding, Alastair Wilkins	62
15	Chemotherapy-induced mesenchymal stem cell damage in patients with hematological malignancy 2010 ·Annals of Hematology ·Kevin Kemp, (unknown), Sarah Wexler, Christine Cox, Elizabeth Mallam, Jill Hows, Craig Donaldson	48
16	Fusion between human mesenchymal stem cells and rodent cerebellar Purkinje cells 2010 ·Neuropathology and Applied Neurobiology ·Kevin Kemp, David J. Gordon, David C. Wraith, Elizabeth Mallam, Elizabeth M. Hartfield, James B. Uney, Alastair Wilkins, Neil Scolding	60
17	Mesenchymal stem cell‐secreted superoxide dismutase promotes cerebellar neuronal survival 2009 ·Journal of Neurochemistry ·Kevin Kemp, Kelly Hares, Elizabeth Mallam, Kate J. Heesom, Neil Scolding, Alastair Wilkins	98
18	Human bone marrow-derived mesenchymal stem cells secrete brain-derived neurotrophic factor which promotes neuronal survival in vitro 2009 ·Stem Cell Research ·Alastair Wilkins, Kevin Kemp, Mark Ginty, Kelly Hares, Elizabeth Mallam, Neil Scolding	225
19	EUV lithography 2006 ·Comptes Rendus Physique ·Kevin Kemp, Stefan Wurm	49
20	ICP-MS, INAA and PIXE analysis of airborne dust samples 1992 ·E.H. Larsen, Asger B. Hansen, L. Kristensen, (unknown), Else Marie Skjøde Damsgaard, K. Heydorn, Kevin Kemp	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact